Cellebrite DI Sees Q1 Sales $126.000M-$128.000M vs $130.637M Est
Benzinga Newsdesk 8 months ago
NewsGuidance
Cellebrite DI (NASDAQ:CLBT) sees Q1 sales of $126.000 million-$128.000 million vs $130.637 million analyst estimate.
Cellebrite DI (NASDAQ:CLBT) sees Q1 sales of $126.000 million-$128.000 million vs $130.637 million analyst estimate.